Generic Advair manufactured in the inhaler from 3M is a big deal. 3M wanted to get back to its roots, manufacturing. Adamis bought the inhaler that contains the 3M generic Advair. Advair is a huge market, a low cost alternative to GSK's Advair is big $$$$$$$$$$$.
Rough week for the stock, but in the long run I believe this is a huge deal. 3M would not have done this deal unless they believed Adamis could execute. The same goes for the initial financing, no one loans over $5 million dollars w/o the belief they will be compensated.
Adamis is not a one trick pony. Check it out and make your decision.
News 
Market Data 
Discover 
